In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors

被引:0
|
作者
Mahmoud A. A. Ibrahim
Alaa H. M. Abdelrahman
Khaled S. Allemailem
Ahmad Almatroudi
Mahmoud F. Moustafa
Mohamed-Elamir F. Hegazy
机构
[1] Minia University,Computational Chemistry Laboratory, Chemistry Department, Faculty of Science
[2] Qassim University,Department of Medical Laboratories, College of Applied Medical Sciences
[3] King Khalid University,Department of Biology, College of Science
[4] South Valley University,Department of Botany & Microbiology, Faculty of Science
[5] National Research Centre,Chemistry of Medicinal Plants Department
来源
The Protein Journal | 2021年 / 40卷
关键词
COVID-19; SARS-CoV-2 main protease; Repositioned drugs; Molecular docking; Molecular dynamics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:296 / 309
页数:13
相关论文
共 50 条
  • [41] On the origins of SARS-CoV-2 main protease inhibitors
    Janin, Yves L.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 81 - 118
  • [42] Peptidomimetic inhibitors of SARS-COV-2 main protease
    Angeles Bonache, Ma.
    Algar, Sergio
    Medina, Jessy
    Diaz-Agustin, Aitor
    Bueno, Paula
    Castro, Victoria
    Fabrega, Montserrat
    Coll, Miquel
    Garaigorta, Urtzi
    Gastaminza, Pablo
    Martin Martinez, Mercedes
    Gonzalez-Muniz, Rosario
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [43] Perspectives on SARS-CoV-2 Main Protease Inhibitors
    Gao, Kaifu
    Wang, Rui
    Chen, Jiahui
    Tepe, Jetze J.
    Huang, Faqing
    Wei, Guo-Wei
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 16922 - 16955
  • [44] Synthesis and In silico Docking Study of Some New Quinazolin-2,4-diones Targeting COVID-19 (SARS-Cov-2) Main Protease: A Search for Anti-Covid19 Drug Candidates
    Ibrahim, Amal O. A.
    Mosallam, Ahmed M.
    Taha, Mohamed M.
    Temairk, Hussain
    Abdelmonsef, Aboubakr H.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2022, 65 (13): : 1553 - 1560
  • [45] Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
    Fiorucci, Diego
    Milletti, Eva
    Orofino, Francesco
    Brizzi, Antonella
    Mugnaini, Claudia
    Corelli, Federico
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (16): : 6242 - 6248
  • [46] Exploring the in-silico approach for assessing the potential of natural compounds as a SARS-CoV-2 main protease inhibitors
    Patel, Ashish
    Patel, Alkesh
    Hemani, Rahul
    Solanki, Riddhi
    Kansara, Janki
    Patel, Gargi
    Pradhan, Sayantan
    Bambharoliya, Tushar
    ORGANIC COMMUNICATIONS, 2021, 14 (01) : 58 - 72
  • [47] Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
    Isgro, Camilla
    Sardanelli, Anna Maria
    Palese, Luigi Leonardo
    VIRUSES-BASEL, 2021, 13 (01):
  • [48] In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro SARS-CoV-2
    Baby, Krishnaprasad
    Maity, Swastika
    Mehta, Chetan
    Suresh, Akhil
    Nayak, Usha Y.
    Nayak, Yogendra
    PHARMACEUTICAL SCIENCES, 2020, 26 : S52 - S62
  • [49] In Silico Identification of Propolis Compounds Potential as COVID-19 Drug Candidates Against SARS-CoV-2 Spike Protein
    Sahlan, Muhamad
    Dewi, Lia Kusuma
    Pratami, Diah Kartika
    Lischer, Kenny
    Hermansyah, Heri
    INTERNATIONAL JOURNAL OF TECHNOLOGY, 2023, 14 (02) : 387 - 398
  • [50] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
    Sharma, Shilpa
    Deep, Shashank
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3003 - 3010